Research & development increased 66.6%
Research & development changed +66.6% from the comparable as-filed period. The change ranks at the 82th percentile of 99 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed +66.6% from the comparable as-filed period. The change ranks at the 82th percentile of 99 prior comparable changes.
Operating margin changed +446 basis points from the comparable as-filed period. The change ranks at the 4th percentile of 69 prior comparable changes.
Debt changed +25.0% from the comparable as-filed period. The change ranks at the 45th percentile of 31 prior comparable changes.
Revenue changed +23.8% from the comparable as-filed period. The change ranks at the 10th percentile of 69 prior comparable changes.
Inventory / revenue changed -1123 basis points from the comparable as-filed period. The change ranks at the 20th percentile of 15 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.